OTLC
Oncotelic Therapeutics, Inc.
OTCHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
Vuong Trieu
IPO Date
1993-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Oncotelic Therapeutics, Inc.
CEO
Vuong Trieu
IPO Date
1993-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 1,500 |
| $0.00 |
| 14 Jul 2026 | Shah Amit B. | CFO | A-Award | Acquired | 1,500 | $0.00 |
| 14 Jul 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | A-Award | Acquired | 2,000 | $0.00 |
| 2 Jul 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 240,000 | $0.04 |
| 24 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 115,000 | $0.04 |
| 24 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 75,000 | $0.04 |
| 24 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 65,000 | $0.04 |
| 22 Jun 2026 | Shah Amit B. | CFO | P-Purchase | Acquired | 20,000 | $0.05 |
| 17 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 239,759 | $0.04 |